Effectiveness OF Guduchi Ghrita in psoriasis.
Phase 2
- Conditions
- Health Condition 1: null- Patients with all forms of Ekkustha(Psoriasis)With Classical Signs Symptoms of Ekkustha(Psoriasis)age limit above 18 years to below 60 yearsHealth Condition 2: L409- Psoriasis, unspecifiedHealth Condition 3: L409- Psoriasis, unspecified
- Registration Number
- CTRI/2017/09/009791
- Lead Sponsor
- Ipgt and Ra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PATIENTS WITH ALL FORMS OF EKKUSTHS(PSORIASIS) WITH CLASSICAL SIGNS AND SYMTOMS OF EKKUSTHA(PSORIASIS)
>18 YEARS to <60 YEARS
Exclusion Criteria
<18 YEARS & >60 YEARS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IT IS EXPECTED THAT TRIAL DRUG WILL EXERT A SIGNIFICANT ACTION ON SIGNS AND SYMTOMS OF PSORIASIS .Timepoint: IT IS EXPECTED THAT TRIAL DRUG WILL EXERT A SIGNIFICANT ACTION ON SIGNS AND SYMTOMS OF PSORIASIS in 2 months period time.
- Secondary Outcome Measures
Name Time Method By providing better effect in general psoriasis disordre,the drug will effect psychosomatic level of the enrolled patients, enhance quality of life and will contribute in reducing disability adjusted life year.Over all improvement in the disease condition, quality of life diseased. <br/ ><br>overall improvment in the disease condition. <br/ ><br>BASED ON THE OBSERVATION.Timepoint: 12 weeks